Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells

Cell Rep. 2021 May 25;35(8):109179. doi: 10.1016/j.celrep.2021.109179. Epub 2021 May 13.

Abstract

Understanding and eliciting protective immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an urgent priority. To facilitate these objectives, we profile the repertoire of human leukocyte antigen class II (HLA-II)-bound peptides presented by HLA-DR diverse monocyte-derived dendritic cells pulsed with SARS-CoV-2 spike (S) protein. We identify 209 unique HLA-II-bound peptide sequences, many forming nested sets, which map to sites throughout S including glycosylated regions. Comparison of the glycosylation profile of the S protein to that of the HLA-II-bound S peptides reveals substantial trimming of glycan residues on the latter, likely induced during antigen processing. Our data also highlight the receptor-binding motif in S1 as a HLA-DR-binding peptide-rich region and identify S2-derived peptides with potential for targeting by cross-protective vaccine-elicited responses. Results from this study will aid analysis of CD4+ T cell responses in infected individuals and vaccine recipients and have application in next-generation vaccine design.

Keywords: HLA class II; HLA-II; LC-MS; SARS-CoV-2; antigen presentation; dentritic cells; glycopeptides; glycoslyation; human leukocyte antigen; immunopeptidomics.

MeSH terms

  • Amino Acid Sequence
  • Antigen Presentation
  • COVID-19 / immunology*
  • COVID-19 / virology
  • Dendritic Cells / immunology*
  • Epitope Mapping
  • Epitopes, T-Lymphocyte / immunology
  • Glycosylation
  • Histocompatibility Antigens Class II / immunology*
  • Humans
  • Peptides / immunology*
  • Protein Binding
  • Protein Interaction Domains and Motifs
  • SARS-CoV-2 / immunology
  • Spike Glycoprotein, Coronavirus / immunology*
  • T-Lymphocytes / immunology

Substances

  • Epitopes, T-Lymphocyte
  • Histocompatibility Antigens Class II
  • Peptides
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2